CE-326,597 100 mg QD
A7211005
Phase 2 small_molecule completed
Quick answer
CE-326,597 100 mg QD for Weight Management is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Weight Management
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed